The first of three trials concerning the drug Mirapex and its link to compulsive behavior began this week in a U.S. District in Minnesota. Mirapex is a drug used to treat Parkinson’s Disease and Restless Leg Syndrome, but recent studies have shown the dopamine agonist can lead to compulsive behavior in many, including compulsive gambling, sexual, and eating behaviors. In June, the largest study ever to investigate the connection between dopamine agonists and compulsive behavior was presented at a conference in Chicago. More than 200 people are currently suing Boehringer Ingelheim, the Pharmaceutical giant that makes Mirapex. Legal experts are looking to the results of these first three trials to gauge the prospects of future cases.
For more information, click here: